About
AAV-Based Gene Therapy
Areas of Focus
Categories
Virus TechnologyGene Therapy, RNA & Peptide TherapyChina
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
2
As Collaborator
1
Total Enrollment
54
By Phase
PHASE1: 2EARLY_PHASE1: 1
By Status
ENROLLING_BY_INVITATION: 2ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
Today
Hover over trial bars to see details
Recent Trials
NCT06737354Lead Sponsor
Safety and Efficacy Study of IVB103 Injection in Subjects With Neovascular (Wet) Agerelated Macular Degeneration (nAMD).
PHASE1Enrolling by invitation
18 participants
Started: Apr 22, 2025 · Completed: Dec 31, 2031
NCT06737354Collaborator
Safety and Efficacy Study of IVB103 Injection in Subjects With Neovascular (Wet) Agerelated Macular Degeneration (nAMD).
PHASE1Enrolling by invitation
18 participants
Started: Apr 22, 2025 · Completed: Dec 31, 2031
NCT06289452Lead Sponsor
Safety and Efficacy Study of IVB102 Injection in Subjects With X-linked Retinoschisis
EARLY_PHASE1Active, not recruiting
18 participants
Started: Mar 8, 2024 · Completed: Dec 31, 2029
Locations (1)
Headquarters
Beijing, China
Map
Loading map...